|
1
|
Berger MS, Deliganis AV, Dobbins J and
Keles GE: The effect of extent of resection on recurrence in
patients with low grade cerebral hemisphere gliomas. Cancer.
74:1784–1791. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Claus EB, Horlacher A, Hsu L, et al:
Survival rates in patients with low-grade glioma after
intraoperative magnetic resonance image guidance. Cancer.
103:1227–1233. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leighton C, Fisher B, Bauman G, et al:
Supratentorial low-grade in adults: an analysis of prognostic
factors and timing of radiation. J Clin Oncol. 15:1294–1301.
1997.PubMed/NCBI
|
|
4
|
Van den Bent MJ, Afra D, de Witte O, et
al: Long-term efficacy of early versus delayed radiotherapy for
low-grade astrocytoma and oligodendroglioma in adults: the EORTC
22845 randomized trial. Lancet. 366:985–990. 2005.PubMed/NCBI
|
|
5
|
Karim AB, Maat B, Hatlevoll R, et al: A
randomized trial on dose-response in radiation therapy of low-grade
cerebral glioma: European Organization for Research and Treatment
of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys.
36:549–556. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaw E, Arusell R, Scheithauer B, et al:
Prospective randomized trial of low versus high-dose radiation
therapy in adults with supratentorial low-grade glioma: initial
report of a North Central Cancer Treatment Group/Radiation Therapy
Oncology Group/Eastern Cooperative Oncology Group study. J Clin
Oncol. 20:2267–2276. 2002. View Article : Google Scholar
|
|
7
|
Lote K, Egeland T, Hager B, et al:
Survival, prognostic factors, and therapeutic efficacy in low-grade
glioma: a retrospective study in 379 patients. J Clin Oncol.
15:3129–3140. 1997.PubMed/NCBI
|
|
8
|
Janny P, Cure H, Mohr M, et al: Low grade
supratentorial astrocytomas: management and prognostic factors.
Cancer. 73:1937–1945. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pignatti F, van den Bent M, Curran D, et
al: Prognostic factors for survival in adult patients with cerebral
low-grade glioma. J Clin Oncol. 20:2076–2084. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicolato A, Gerosa MA, Fina P, Iuzzolino
P, Giorgiutti F and Bricolo A: Prognostic factors in low-grade
supratentorial astrocytomas: a uni-multivariate statistical
analysis in 76 surgically treated patients. Neurosurgery.
44:208–223. 1995.
|
|
11
|
Soffietti R, Chiò A, Giordana MT, Vasario
E and Schiffer D: Prognostic factors in well-differentiated
cerebral astrocytomas in the adult. Neurosurgery. 24:686–692. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shibamoto Y, Kitakabu Y, Takahashi M, et
al: Supratentorial low-grade astrocytoma. Correlation of computed
tomography findings with effect of radiation therapy and prognostic
variables. Cancer. 72:190–195. 1993. View Article : Google Scholar
|
|
13
|
Vecht CJ: Effect of age on treatment
decisions in low-grade glioma. J Neurol Neurosurg Psychiatry.
56:1259–1264. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Veelen ML, Avezaat CJ, Kros JM, van
Putten W and Vecht C: Supratentorial low grade astrocytoma:
prognostic factors, dedifferentiation, and the issue of early
versus late surgery. J Neurol Neurosurg Psych. 64:581–587.
1998.PubMed/NCBI
|
|
15
|
Bauman G, Fischer B, Walting C, Cairncross
JG and Macdonald D: Adult Supratentorial low-grade gliomas: long
experience at a single institution. J Radiat Oncol Biol Phys.
75:1401–1407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauman G, Pahapill P, Macdonald D, Fisher
B, Leighton C and Cairncross G: Low grade glioma: a measuring
radiographic response to radiotherapy. Can J Neurol Sci. 26:18–22.
1999.PubMed/NCBI
|
|
17
|
Eyre HJ, Crowley JJ, Townsend JJ, et al: A
randomized trial of radiotherapy versus radiotherapy plus CCNU for
incompletely resected low-grade gliomas: a Southwest Oncology Group
study. J Neurosurg. 78:909–914. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lunsford LD, Somaza S, Kondziolka D and
Flickenger JC: Survival after stereotactic biopsy and radiation of
cerebral non pilocytic astrocytoma. J Neurosurg. 82:523–529. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shaw EG, Berkey B, Coons SW, et al:
Initial report of Radiation Therapy Oncology Group (RTOG) 9802:
Prospective studies in adult low-grade glioma (LGG). ASCO 2006
Annual Meeting Proceedings. J Clin Oncol. 24:Abstr 1500. 2006.
|
|
20
|
Quinn JA, Reardon DA, Friedman AH, et al:
Phase II trial of temozolomide in patients with progressive
low-grade glioma. J Clin Oncol. 21:646–651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van den Bent MJ, Taphoorn MJ, Brandes AA,
et al: Phase II study of first-line chemotherapy with temozolomide
in recurrent oligodendroglial tumors: the European Organization for
Research and Treatment of Cancer Brain Tumor Group study 26971. J
Clin Oncol. 21:2525–2528. 2003.PubMed/NCBI
|
|
22
|
van den Bent MJ, Chinot O, Boogerd W, et
al: Second-line chemotherapy with temozolomide in recurrent
oligodendroglioma after PCV (procarbazine, lomustine and
vincristine) chemotherapy: EORTC Brain Tumor Group phase II study
26972. Ann Oncol. 14:599–602. 2003.
|
|
23
|
Hoang-Xuan K, Capelle L, Kujas M, et al:
Temozolomide as initial treatment for adults with low-grade
oligodendrogliomas or oligoastrocytomas and correlation with
chromosome 1p deletions. J Clin Oncol. 22:3133–3138. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buckner JC, Gesme D Jr, O’Fallon JR, et
al: Phase II trial of procarbazine, lomustine, and vincristine as
initial therapy for patients with low-grade oligodendroglioma or
oligoastrocytoma: efficacy and associations with chromosomal
abnormalities. J Clin Oncol. 21:251–255. 2003. View Article : Google Scholar
|
|
25
|
Brada M, Viviers L, Abson C, et al: Phase
II study of primary temozolomide chemotherapy in patients with WHO
grade II gliomas. Ann Oncol. 14:1715–1721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pace A, Vidiri A, Galiè E, Carosi M,
Telera S, Cianciulli AM, et al: Temozolomide chemotherapy for
progressive low-grade glioma: clinical benefits and radiological
response. Ann Oncol. 14:1722–1726. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stege EM, Kros JM, de Bruin HG, et al:
Successful treatment of low-grade oligodendroglial tumors with a
chemotherapy regimen of procarbazine, lomustine, and vincristine.
Cancer. 103:802–809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chahlavi A, Kanner A, Peereboom D,
Staugaitis SM, Elson P and Barnett G: Impact of chromosome 1p
status in response of oligodendroglioma to temozolomide:
preliminary results. J Neurooncol. 61:267–273. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jenkins RB, Blair H, Ballman KV, et al: A
t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and
predicts a better prognosis of patients with oligodendroglioma.
Cancer Res. 66:9852–9861. 2006. View Article : Google Scholar : PubMed/NCBI
|
